Trials / Completed
CompletedNCT00424580
Airway Responses to Montelukast and Desloratadine.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (planned)
- Sponsor
- University of Saskatchewan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Montelukast (for asthma) and desloratadine (for allergies) are effective therapy for their current uses. Part of what happens when your allergies trigger your asthma should be prevented by either of these drugs. This project is being conducted to determine if these drugs are effective, either alone or in combination, on controlling asthma that is triggered by allergies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Montelukast (10mg) and Desloratadine (5mg) |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2007-01-19
- Last updated
- 2008-01-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00424580. Inclusion in this directory is not an endorsement.